Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma
Clinical trial NCT01307592 · UNKNOWN
Trial details
- NCT number
- NCT01307592
- Sponsor
- Auxilio Mutuo Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-02-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.